Rare KRAS G12C mutation emerges as potential target in genitourinary cancers
For nearly four decades, KRAS occupied a paradoxical position in cancer biology: it was the most intensively studied oncogene in ...
For nearly four decades, KRAS occupied a paradoxical position in cancer biology: it was the most intensively studied oncogene in ...
Researchers at Purdue University have developed a small-molecule compound that could open a new route toward cancer immunotherapy by targeting ...
A two-headed experimental drug has eradicated aggressive human lymphoma tumors in mice by turning one of cancer’s most important growth-driving ...
Cancer cells do not merely consume more nutrients than healthy cells; they redesign the systems that process those nutrients to ...
Although modern cancer treatments can eliminate malignant cells with remarkable efficiency, their lack of perfect selectivity often exposes healthy tissues ...
A protein that helps cancer cells control oxidative stress may explain why some blood cancers eventually stop responding to BTK ...
UCLA researchers have identified a way to make antibody-drug conjugates more powerful against metastatic castration-resistant prostate cancer, an advanced form ...
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1) ...
A new study in Nature Communications reveals how cancer cells can use the body’s own defenses against them. The work, ...
A groundbreaking study published in Nature Communications unveils a novel approach to treating brain metastases with unprecedented precision and efficacy. ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine